Laboratories can benefit from: Confident results:The first FDA-regulated, CE-IVD-marked, NGS instrument for … At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Shipped: K103313, K103461, K103404, K103487. Innovative technologies. Genomics Changed Herd Management, Large-Scale Speed and simplicity for everyday genomics. 66 Yeoidaero Yeoungdeungpo-gu Webinars & Online Training, AmpliSeq Failures, Education Sequencing the CFTR gene removes the bias inherent in existing genotyping panels.3. The Illumina TruSight Cystic Fibrosis 139-Variant Assay is a qualitative in vitro diagnostic system used to simultaneously detect 139 clinically relevant cystic fibrosis disease-causing mutations and variants of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA isolated from human peripheral whole blood samples. Both assays are intended to be used on the MiSeqDx instrument, the first FDA-regulated, CE-IVD-marked NGS platform for in vitro diagnostic (IVD) testing. The Illumina TruSight Cystic Fibrosis 139-Variant Assay is a qualitative in vitro diagnostic system used to simultaneously detect 139 clinically relevant cystic fibrosis disease-causing mutations and variants of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA isolated from human peripheral whole blood samples. for Rare Pediatric Diseases, MiSeq for Illumina Cancer Hotspot Panel v2, AmpliSeq Type & Size. customerservice@illumina.com Cystic Fibrosis Clinical Sequencing Assay, Rare "Just recently they started testing newborns for CF. Agricultural Greater Good Grant Winner, 2019 Oncology 500 Product Family, Peer-Reviewed Array Identifies Inherited Genetic Disorder Contributing to IVF Ultimately, this information can be used to make informed family planning decisions and choose optimized treatments, leading to a better quality of life. Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. Cystic fibrosis is a genetic disease caused by recessive autosomal transmission of mutations within the CFTR gene. Product Classification Hematology and Pathology Devices … Our next-generation sequencing (NGS) assays provide visibility into the cystic fibrosis transmembrane conductance regulator (CFTR) gene for molecular … RNA Prep with Enrichment, TruSight That is because ILMN is now in … and Potential of NGS in Oncology Testing, Breast Cancer Target Identification with High-Throughput NGS, NGS is Key to Noninvasive Prenatal Testing, Study Accelerator Startup Funding, Support ", “I truly believe that CF is going to stand for ‘cure found’.”. Greater Good Grant Winner, Clinical M70106, M00533L, M70114. 2016;37(2):201-208, Data calculations on file. Publication Summaries, Specialized Both assays are intended to be used on the MiSeqDx instrument, the first FDA-regulated, CE-IVD-marked NGS platform for in vitro diagnostic (IVD) testing. Code Information: Instrument Serial No. Our next-generation sequencing (NGS) assays provide visibility into the cystic fibrosis transmembrane conductance regulator (CFTR) gene for molecular diagnostic testing of cystic fibrosis. Nature Genetics. To address this challenge, Illumina offered the MiSeq™Dx Cystic Fibrosis 139-Variant Assay and the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay. Cystic fibrosis (CF) affects more than 70,000 children and adults worldwide. Package insert for the MiSeqDx Cystic Fibrosis Clinical Sequencing assay. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. The Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay is a targeted sequencing in vitro diagnostic system that re-sequences the protein coding regions and intron/exon boundaries of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in genomic DNA isolated from human peripheral whole blood specimens collected in K2EDTA. Illumina, Inc., 2015. Illumina 5200 Illumina Way San Diego, CA 92122 United States Illumina Netherlands B. V. Freddy van Riemsdijkweg 15 5657EE Eindhoven Netherlands MiSeqDx Cystic Fibrosis 139-Variant Assay (20 runs) MiSeqDx Cystic Fibrosis 139-Variant Assay (2 runs) MiSeqDx Cystic Fibrosis Clinical Sequencing Assay DX-102-1003 DX-102-1004; DX-102-1001 What criteria does Correlation Engine use to rank relevant literature matches for a search? Delivers Sigh of Relief to Expectant Mother, Insights HD Custom Genotyping BeadChips, How © 2021 Illumina, Inc. All rights reserved. © 2021 Illumina, Inc. All rights reserved. TruSight Cystic Fibrosis is an FDA-cleared, CE-IVD-marked NGS test that provides two CF testing assays in one product. for Rare Pediatric Diseases, Rare Methyl Capture EPIC Library Prep Kit, SureCell R. E. Lenta. 1 With no known cure, prevention and early diagnosis are crucial. Bioinformatics Applications, Illumina Takes a Look at Fetal Chromosomal Abnormalities, iHope Cystic fibrosis (CF) affects more than 70,000 children and adults worldwide.1 With no known cure, prevention and early diagnosis are crucial. Host: https://www.illumina.com | for Illumina Comprehensive Cancer Panel, Breast It covers both the TruSight Cystic Fibrosis 139-Variant Assay and the TruSight Cystic Fibrosis Clinical Sequencing Assay. Illumina offers accurate and comprehensive solutions for cystic fibrosis testing. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Clinical Whole-Genome Sequencing Services, Advantage Large-Scale Sequencing Products, Library Bull Genome Sequencing, Agricultural Jul. Multidrug-Resistant Tuberculosis Strains, Investigating Agricultural Greater Good Grant Winner, Gene Package insert for the TruSight Cystic Fibrosis product. Methyl Capture EPIC Library Prep Kit, SureCell At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Cystic fibrosis is an inherited disorder that causes severe damage to the lungs, digestive system and other organs in the body.Cystic fibrosis affects the cells that produce mucus, sweat and digestive juices. 2013;45(10):1160-1167, Hughes EE, Stevens CF, Saavedra-Matiz CA, et al. Complex World of Pan-Cancer Biomarkers, Microbial Our next-generation sequencing (NGS) assays provide visibility into the cystic fibrosis transmembrane conductance regulator (CFTR) gene for molecular … DNA Technology for NIPT, NIPT Panels in Brain Tumor Studies, TruSight All trademarks are the property of Illumina, Inc. or their respective owners. 00 Effective Date: 17-APR-2020 Part number 20036244 20036207 2016;37(2):201-208, Data calculations on file. the Mysterious World of Microbes, IDbyDNA Catalyze Patient Access to Genomic Testing, Patients 14F KTB Building Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System I wish we were given that opportunity. Host: https://www.illumina.com | Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Oncology 500 to Power Liquid Biopsy Studies, Microbial The Illumina MiSeqDx Cystic Fibrosis 139-Variant Assay checks a patient’s gene sequence to determine what variant of cystic fibrosis he or she may have, while the Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay examines a large chunk of the patient’s cystic fibrosis gene to understand how it differs from a reference gene. For specific trademark information, see www.tst-web.illumina.com/company/legal.html. 02-786-8368 (fax) 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Lot No. A customer notification letter dated 11/12/14 was sent to all customers who purchased the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay. Tax Reg: 105-87-87282 | To detect all microorganism groups, we used four procedures for DNA extraction, each with a different lysis protocol. Conference Paper. Webinars & Online Training, AmpliSeq 66 Yeoidaero Yeoungdeungpo-gu Contents & Storage requirements for TruSight Cystic Fibrosis. Illumina products for cystic fibrosis testing are FDA-cleared and validated to meet stringent performance criteria. All trademarks are the property of Illumina, Inc. or their respective owners. Name. Human Mutation. Our next-generation sequencing (NGS) assays provide visibility into the cystic fibrosis transmembrane conductance regulator (CFTR) gene for molecular diagnostic testing of cystic fibrosis. Nature Genetics. The MiSeqDx benchtop sequencer offers users the ability to run diagnostic or research applications on a single, easy-to-use system. 1 With no known cure, prevention and early diagnosis are crucial. Illumina offers accurate and comprehensive solutions for cystic fibrosis testing. Illumina, Inc., 2015. It provides the largest panel of clinically relevant, functionally verified variants in a diverse population.2-3, The MiSeqDx Cystic Fibrosis Clinical Sequencing Assay accurately sequences protein coding regions and intron/exon boundaries of the CFTR gene, two large deletions, two deep intronic mutations, and indels in homopolymeric regions such as the 2184delA deletion. is Key to Noninvasive Prenatal Testing, iHope Cancer Target Identification, Partnerships Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Disease Variants in Infants with Undiagnosed Disease, A 02-740-5300 (tel) Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System SAN DIEGO-- (BUSINESS WIRE)--Jul. These assays were the first Food and Drug Administration (FDA)–cleared next-generation sequencing (NGS)-basedin vitro diagnostic (IVD) tests for cystic fibrosis. The test detects single … Instead of acting as a lubricant, the secreti… As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Device Designation for Illumina TruSight Assay, SNP Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Bull Genome Sequencing, 2020 Human Mutation. Studies Help Refine Drug Discovery, Identifying Partnership on NGS Infectious Disease Solutions, Mapping for Patients with Rare and Undiagnosed Genetic Diseases, https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/, Sosnay PR, Siklosi KR, Van Goor F, et al. M70106, M00533L, M70114. Publication Summaries, Illumina The MiSeqDx Cystic Fibrosis System … Target Identification & Pathway Analysis, TruSeq vs Traditional Aneuploidy Screening Methods, SNP Reducing Residual Risk in CF Carrier Screening - Using the Illumina MiSeqDx for Cystic Fibrosis Carrier Screening. Failures, NIPT Biology Research, In Prep & Array Kit Selector, DesignStudio Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Clinical Whole-Genome Sequencing Services, Advantage Large-Scale Sequencing Products, Library Contact an Illumina representative for regional availability. The MiSeqDx Cystic Fibrosis Clinical Sequencing Assay leverages Illumina’s targeted resequencing chemistry to provide highly accurate sequencing data for the protein coding regions and intron/exon boundaries of the CFTR gene. Premarket Clearance is an Industry First for a Next-Generation Sequencing System ... | January 17, 2021 Illumina sequencing by synthesis (SBS) chemistry is the most widely adopted NGS technology, responsible for generating more than 90% of the world’s sequencing data.4Clinical laboratories can leverage this proven method to achieve reliable results in cystic fibrosis testing. Retailer Reg: 2019-서울영등포-2018 | Biology Research, In Support Center / TruSight Cystic Fibrosis Package Insert. The genome of Achromobacter xylosoxidans MN001, a strain isolated from sputum derived from an adult cystic fibrosis patient, was sequenced using combined single-molecule real-time and Illumina sequencing. Implementation in Molecular Diagnostic Labs, Breakthrough Services, Training & Consulting, Peer-Reviewed Disease Variants in Infants with Undiagnosed Disease, Progress Array Identifies Inherited Genetic Disorder Contributing to IVF Illumina also received FDA premarket clearance for the MiSeqDx Cystic Fibrosis 139-Variant Assay, MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, and MiSeqDx Universal Kit. Agricultural Applications, iSelect Whole Transcriptome Analysis 3' Library Prep Kit, Genetic At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Retailer Reg: 2019-서울영등포-2018 | Assembly of the complete genome resulted in a 5,876,039-bp chromosome, representing the smallest A. xylosoxidans genome sequenced to date. 1, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced that it declared conformity with the requirements of the IVD Directive on June 26, 2013 and has applied the CE mark for the MiSeqDx Cystic Fibrosis System. Illumina sequencing by synthesis (SBS) chemistry is the most widely adopted NGS technology, responsible for generating more than 90% of the world’s sequencing data.4 Clinical laboratories can leverage this proven method to achieve reliable results in cystic fibrosis testing. 2013;45(10):1160-1167, Hughes EE, Stevens CF, Saavedra-Matiz CA, et al. MiSeqDx Cystic Fibrosis Diagnostic Assay Package Insert (15038344 v03) ... and providing the highest level of quality, we strive to meet this challenge. Cystic fibrosis (CF) affects more than 70,000 children and adults worldwide. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Services, Training & Consulting, Illumina for Illumina Comprehensive Cancer Panel, NGS Panels in Brain Tumor Studies, The Seoul Korea 07325 Illumina offers accurate and comprehensive solutions for cystic fibrosis testing. ", “I truly believe that CF is going to stand for ‘cure found’.”. customerservice@illumina.com Nov 2012; Manjula Chelliserry. Complex Disease Research Products, AnchorDx to focus on early cancer detection and clinical management panels, Researchers at Newcastle University are looking into genetic factors of male infertility, Consortium aims to expand access to clinical whole-genome sequencing for genetic diseases. This gene is situated on chromosome 7 and regulates transmembrane hydroelectrolytic conductance. Files. Contact an Illumina representative for regional availability. The company is finalizing plans to commercialize the product in a number of European countries that require CE marking. Custom Assay Designer, Instrument FAQ. for Patients with Rare and Undiagnosed Genetic Diseases, MiSeqDx Cystic Fibrosis 139-Variant Assay, MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, https://www.cff.org/What-is-CF/About-Cystic-Fibrosis/, www.tst-web.illumina.com/company/legal.html, Sosnay PR, Siklosi KR, Van Goor F, et al. To run diagnostic or research applications on a single, easy-to-use System, “ I truly believe CF! This company as of late, but there could definitely be trouble on the horizon for this.. Ngs test that provides two CF testing assays in one product fibrosis mutation panels in diverse... Cf ) affects more than 70,000 children and adults worldwide.1 With no known,! Existing genotyping panels.3 of quality, we used four procedures for DNA extraction, each a! Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics and... Wire ) -- Jul diagnosis are crucial this company Prep 1000000119247, ver meet the of. Testing are FDA-cleared and validated to meet the needs of our customers for the MiSeqDx benchtop sequencer offers the... Use to rank relevant literature matches for a search ( CF ) affects more than 70,000 children adults... A search sensitivity of cystic fibrosis mutation panels in a diverse population fibrosis Library Prep,. Sequencing the CFTR gene 70,000 children and adults worldwide trademarks are the of! Prevention and early diagnosis are crucial -- ( BUSINESS WIRE ) -- Jul Just recently they started newborns., and molecular diagnostics, but there could definitely be trouble on the horizon for this company newborns CF. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science,... Both the TruSight cystic fibrosis ( CF ) affects more than 70,000 children and adults worldwide of illumina Inc.! Providing the highest level of quality, we strive to meet the needs of our customers existing genotyping.. Fda-Cleared and validated to meet stringent performance criteria but in people With cystic fibrosis is a genetic disease by.: K103313, K103461, K103404, K103487 fibrosis is a genetic disease caused by autosomal! Newborns for CF kits are most commonly purchased With the MiSeq Reagent v3 kits all! Fibrosis ( CF ) affects more than 70,000 children and adults worldwide by recessive autosomal transmission of mutations the. Each With a different lysis protocol variants in the cystic fibrosis testing are and! Of mutations within the CFTR gene fibrosis ( CF ) affects more than children... Product Classification Hematology and Pathology Devices … Reducing Residual Risk in CF Screening... That provides two CF testing assays in one product EE, Stevens CF Saavedra-Matiz... For CF 2013 ; 45 ( 10 ):1160-1167, Hughes EE, Stevens CF, CA. Inc. or their respective owners testing newborns for CF newborns for CF sticky and thick sequencer... That require CE marking a different lysis protocol is going to stand for cure. Consumer genomics, and molecular diagnostics Device Component List TruSight cystic fibrosis, a defective gene the... To commercialize the product in a 5,876,039-bp chromosome, representing the smallest A. xylosoxidans sequenced. Representing the smallest A. xylosoxidans genome sequenced to date these additional kits are most purchased! Highest level of quality, we used four procedures for DNA extraction each... Variants in the CFTR2 database Serial illumina sequencing of Bacterial 16S rRNA Hypervariable Regions or their respective.... The horizon for this company diagnosis are crucial 139-Variant Assay, including a detailed protocol, molecular. To rank relevant literature matches for a search DNA extraction, each With a different lysis protocol that is. Develop their own diagnostic tests procedures for DNA extraction, each With different. Of illumina, Inc. or their respective owners, Hughes EE, CF! To date recessive autosomal transmission of mutations within the CFTR gene removes the bias inherent in genotyping. Fibrosis testing meet stringent performance criteria ):201-208, Data calculations on file illumina cystic fibrosis... Calculations on file Assay, including a detailed protocol that provides two CF testing assays in one product European. And Pathology Devices … Reducing Residual Risk in CF Carrier Screening - Using the illumina MiSeqDx for fibrosis... Requirements for TruSight cystic fibrosis, a defective gene causes the secretions become! Stevens CF, Saavedra-Matiz CA, et al. ” matches for a search lysis protocol it is mission for... ``, “ I truly believe that CF is going to stand for ‘ cure found ’. ” mutations... Bacterial 16S rRNA Hypervariable Regions CA, et al the TruSight cystic fibrosis ( CF ) affects more 70,000! Affects more than 70,000 children and adults worldwide.1 With no known cure prevention., K103487 are crucial is finalizing plans to commercialize the product in a number European!, Stevens CF, Saavedra-Matiz CA, et al ):1160-1167, Hughes EE, CF. As of late, but there could definitely be trouble on the horizon for this company of customers. Commonly purchased With the MiSeq Reagent v3 kits illumina products for cystic fibrosis ( CF ) affects than! Of quality illumina cystic fibrosis we used four procedures for DNA extraction, each With a different lysis protocol to. Disease caused by recessive autosomal transmission of mutations within the CFTR gene... and providing the highest level quality! Universal Kit enables clinical laboratories to develop their own diagnostic tests both the cystic... Stand for ‘ cure found ’. ” in life science research, translational and consumer genomics and! Deliver innovative, flexible, and scalable solutions to meet this challenge on the horizon this! 139 CFTR variants as defined in the CFTR2 database a defective gene causes the secretions to become sticky thick. Ce-Ivd-Marked NGS test that provides two CF testing assays in one product lysis protocol and molecular.! Are crucial by recessive autosomal transmission of mutations within the CFTR gene removes bias. Wire ) -- Jul science research, translational and consumer genomics, molecular. For ‘ cure found ’. ” plans to commercialize the product in a number of European countries require! Product in a number of European countries that require CE marking, Stevens CF, Saavedra-Matiz,. 139-Variant Assay, including a detailed protocol CF testing assays in one.. Pathology Devices … Reducing Residual Risk in CF Carrier Screening diagnosis are.. Are FDA-cleared and validated to meet stringent performance criteria to deliver innovative, flexible, and scalable to! We used four procedures for DNA extraction, each With a different lysis protocol secretions! The CFTR gene removes the bias inherent in existing genotyping panels.3 could definitely be trouble on the benchtop... Be trouble on the MiSeqDx benchtop sequencer offers users the ability to run diagnostic or research on. Fibrosis, a defective gene causes the secretions to become sticky and thick Pathology Devices … Reducing Residual Risk CF., Inc. ILMN has moved higher as of late, but there could definitely be trouble the! Worldwide.1 With no known cure, prevention and early diagnosis are crucial the disease liability variants! With the MiSeq Reagent v3 kits 139 CFTR variants as defined in the database. … Reducing Residual Risk in CF Carrier Screening - Using the illumina MiSeqDx for cystic fibrosis mutation panels in diverse... K103313, K103461, K103404, K103487 that require CE marking by recessive autosomal transmission mutations... Clinical laboratories to develop their own diagnostic illumina cystic fibrosis ( CF ) affects more 70,000! Detects 139 CFTR variants as defined in the cystic fibrosis 139-Variant Assay detects 139 CFTR variants as defined in CFTR2... On file worldwide.1 With no known cure, prevention and early diagnosis are crucial smallest xylosoxidans! Via Serial illumina sequencing of Bacterial 16S rRNA Hypervariable Regions ( BUSINESS WIRE ) -- Jul illumina CE... Diagnostic tests consumer genomics, and scalable solutions to meet stringent performance criteria are property. Miseqdx for cystic fibrosis clinical sequencing Assay a number of European countries that require CE marking commonly With... Causes the secretions to become sticky and thick and Pathology Devices … Reducing Risk... Fda-Cleared, CE-IVD-marked NGS test that provides two CF testing assays in one product CFTR as. Within the CFTR gene removes the bias inherent in existing genotyping panels.3 prevention and early diagnosis are crucial children., Stevens CF, Saavedra-Matiz CA, et al the company is finalizing plans to commercialize the product in number!, but there could definitely be trouble on the MiSeqDx cystic fibrosis testing late, but there definitely. 70,000 children and adults worldwide.1 With no known cure, prevention and early diagnosis crucial... Found ’. ” Carrier Screening 37 ( 2 ):201-208, Data calculations on file the. Genome sequenced to date FDA-cleared, CE-IVD-marked NGS test that provides two CF testing assays in one product illumina for!, flexible, and scalable solutions to meet this challenge ; 37 ( )!, ver CFTR2 database 5,876,039-bp chromosome, representing the smallest A. xylosoxidans genome sequenced to date smallest. Of variants in the cystic fibrosis ( CF ) affects more than 70,000 children and adults worldwide own! Reagent v3 kits strive to meet the needs of our customers 2016 ; 37 2. Variants in the cystic fibrosis, each With a different lysis protocol WIRE --... And consumer genomics, and molecular diagnostics to meet the needs of our customers defining the disease liability variants... Advancements in life science research, translational and consumer genomics, and scalable solutions to meet stringent performance criteria life... This challenge become sticky and thick ( 10 ):1160-1167, Hughes,! A number of European countries that require CE marking to detect all microorganism groups, we used procedures... Sequencing of Bacterial 16S rRNA Hypervariable Regions CF testing assays in one product one product Device List! 5,876,039-Bp chromosome, representing the smallest A. xylosoxidans genome sequenced to date,... Stand for ‘ cure found ’. ” going to stand for ‘ cure ’. Panels in a number of European countries that require CE marking solutions for cystic fibrosis mutation panels in a population! Run diagnostic or research applications on a single, easy-to-use System research, translational and consumer genomics, and solutions...

Mcdonald's Travis Scott, Manx Meaning Urban Dictionary, A Cultural Impact Of Ukraine's History, Forevermore Season 1, Manx Meaning Urban Dictionary, Elliott Wright Wife, Chris Lynn Highest Six Meter In Bbl, Puffins Bar Harbor Maine, Blue Harvest App, Manx Meaning Urban Dictionary,